Ezetimibe
Product Images NDC 0591-3713

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 0591-3713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure of Ezetimibe, a drug used for further processing. The diagram shows atoms and bonds representing the molecular arrangement, including aromatic rings, hydroxyl groups, fluorine atoms, and a beta-lactam ring.*

FDA Label Image

10 mg (Image 2)

Label for Ezetimibe Tablets USP 10 mg, showing 30 tablets per package. The label indicates the product is distributed by Actavis Pharma, Inc. and manufactured in India by Watson Pharma Private Limited. It includes storage instructions, dosage note to see insert, and a barcode with NDC 0591-3713-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.